A neurotransmitter is released from one neuron, drifts across the synaptic gap, binds to receptors on the next cell to pass the signal, and is then cleared away by reuptake or breakdown so the synapse can reset. That four-beat cycle, release, cross, bind, clear, is the whole of neurotransmission, and it is also where most brain-acting drugs do their work.
First, five words worth knowing
The mechanism is easier to follow with a small vocabulary in hand. These are the terms that keep coming up.
- Synapse
- The junction where one neuron meets the next. The two cells do not touch; a tiny gap, the synaptic cleft, sits between them.
- Receptor
- A protein on the receiving cell shaped to fit a particular neurotransmitter. When the two meet, the receptor passes the signal on.
- Reuptake
- The sending cell reabsorbing its neurotransmitter from the gap after use, switching the signal off and recycling the chemical.
- Agonist
- A substance that binds a receptor and activates it, mimicking or boosting the natural neurotransmitter's effect.
- Antagonist
- A substance that binds a receptor and blocks it, sitting in the way so the natural neurotransmitter cannot act.
The synaptic cycle, step by step
Here is the journey of a single signal, from the moment an electrical pulse arrives at the end of a neuron to the moment the synapse is ready to fire again. The whole sequence repeats endlessly, billions of times a second, all over the brain.
The signal arrives and triggers release
An electrical pulse travels down the sending neuron and reaches its tip. There, it causes tiny membrane-wrapped packets called vesicles, each stuffed with neurotransmitter, to fuse with the cell's edge and spill their contents into the synaptic gap. The electrical message has just become a chemical one.
The messenger crosses the gap
The released neurotransmitter molecules diffuse across the synaptic cleft. The distance is astonishingly small, so the crossing takes almost no time. This gap is the whole reason chemical messengers exist: without it, the neurons could be wired directly, but there would be no room for the tuning and flexibility the chemistry provides.
The messenger binds to receptors
On the far side, the molecules lock onto receptors, proteins shaped to fit them like a key in a lock. Binding changes the receiving cell: depending on the receptor, it nudges the cell towards firing its own signal or holds it back. Crucially, the effect is set by the receptor, not the chemical alone, which is why the same neurotransmitter can do different things in different places.
The signal is switched off, and the gap is cleared
A signal that never ended would be useless, so the neurotransmitter must be removed promptly. This happens two main ways: reuptake, where the sending cell reabsorbs the molecules to use again, and breakdown, where enzymes chop them up in the gap. Either way the cleft is cleared, the receptors are freed, and the synapse resets, ready for the next pulse.
The signal is defined as much by its ending as by its arrival. Clearing the gap promptly is not clean-up after the message: it is part of the message.
Where drugs step into the cycle
Almost every substance that changes how you feel, from medicines to caffeine to recreational drugs, does so by acting at one of these four steps. Once you can see the cycle, you can see where each one intervenes, and it demystifies a great deal of pharmacology.
Some drugs are agonists: they bind receptors and activate them, standing in for the natural messenger. Some are antagonists: they bind receptors and block them, jamming the lock so the real key cannot turn. Others act not on receptors but on clean-up, and this is where one of the most talked-about classes of medicine lives. A reuptake inhibitor slows the reabsorption step, so the neurotransmitter lingers longer in the gap and keeps acting on receptors. That is precisely how SSRIs, selective serotonin reuptake inhibitors, work: they block the transporter that would normally pull serotonin back out of the cleft, leaving more of it in play.
An honest boundary. What an SSRI does to the cycle is clear and well understood: it slows serotonin reuptake, raising serotonin in the synapse. Why that helps some people with depression is a separate, murkier question, and the two must not be run together. Knowing the mechanism of the drug is not the same as knowing the cause of the condition, and a working treatment does not prove any particular story about what went wrong. We keep those threads carefully apart on the mental health page.
Other familiar examples slot in just as neatly. Caffeine is an antagonist: it blocks receptors for a molecule that would otherwise make you sleepy, which is why it keeps you alert. Many anti-anxiety medicines and alcohol boost the effect of inhibitory GABA, slowing the whole system. Nicotine mimics acetylcholine at certain receptors. In each case the drug is not doing anything mysterious; it is pulling one of the four levers in the cycle you have just followed.
Seeing the cycle also makes sense of two things that often puzzle people. The first is why some medicines take weeks to work even though their immediate action on the cycle is fast. An SSRI raises synaptic serotonin within hours, yet any benefit for mood typically appears only after weeks. That gap is a strong hint that the useful effect is not the raised serotonin itself but slower downstream changes it sets in motion, in how neurons connect and adapt. The second is why stopping some drugs abruptly can jolt the system: the brain adjusts its receptors to the drug's presence over time, so removing it suddenly leaves that adjustment stranded until it can settle back. Both puzzles dissolve once you picture the cycle as something the brain adapts around, not a static tap.
Why the cycle is so elegant
Step back and the design is genuinely beautiful. A signal that is fast when it needs to be fast, precise because the receptor decides the meaning, adjustable because dozens of different messengers and receptors can be mixed, and self-limiting because clean-up is built in. It is this last feature, the crisp switching-off, that lets the brain send discrete, well-timed messages rather than a smeared, endless hum. The elegance is also why the system is such a rich target for medicine: there are many precise points at which a molecule can nudge the process one way or another.
It also explains why simple stories go wrong. Because meaning lives in the receptor and the circuit, not in the chemical alone, you cannot read off a mental state from the level of any one transmitter. The cycle is the same everywhere; what differs is the wiring it runs through. That is the deeper lesson of the mechanism, and it is the thread that runs through every page in this section.
There is one further subtlety worth carrying away. The same neurotransmitter can meet several different types of receptor, and each type can produce a different effect on the receiving cell. Serotonin, for instance, acts on more than a dozen distinct receptor subtypes, some excitatory, some inhibitory, scattered across different circuits. This is why a single messenger can do so many apparently unrelated jobs, and why a drug that raises the level of a transmitter does not raise one clean effect but touches every receptor that transmitter reaches. The receptor, in other words, is where the real specificity lives. Once that clicks, the whole business of neurotransmission stops looking like plumbing and starts looking like language, where the same word can mean different things depending on who is listening and where.
Where to go next
You now know how any messenger delivers its signal. To see which messengers do what, revisit key neurotransmitters. To follow the reuptake story into the debate about mood and medication, read neurotransmitters and mental health. And for the state of the evidence overall, see the research page.
Sources
- Kandel ER, Schwartz JH, Jessell TM, et al. Principles of Neural Science. 6th ed. McGraw-Hill; 2021.
- Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 6th ed. Oxford University Press; 2018.
- Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain. 4th ed. Wolters Kluwer; 2016.
This page is educational and explains general neuroscience. It is not medical advice and does not diagnose or treat any condition, and nothing here should be read as a reason to start or stop any medication.